Oscar R. Miranda, Phd/Mba/Be (He/Him)

Oscar R. Miranda, Phd/Mba/Be (He/Him) Email and Phone Number

Biopharmaceutical Drug Product Development; DDS/Formulation; PK/PD Studies; Innovator/Inventor; Preclinical Genes & Cells Therapeutics Product Development Scientific Director; Entrepreneur; and BioMedical Engineer Leader @
Oscar R. Miranda, Phd/Mba/Be (He/Him)'s Location
Cambridge, Massachusetts, United States, United States
Oscar R. Miranda, Phd/Mba/Be (He/Him)'s Contact Details

Oscar R. Miranda, Phd/Mba/Be (He/Him) work email

Oscar R. Miranda, Phd/Mba/Be (He/Him) personal email

n/a

Oscar R. Miranda, Phd/Mba/Be (He/Him) phone numbers

About Oscar R. Miranda, Phd/Mba/Be (He/Him)

SummaryA STEM knowledgeable, resourceful, highly motivated and focus matched Biopharmaceutical Scientist, BioMedical Engineer, Preclinical Genes and Cells Therapeutics Drug Product Development Director, Innovator/Inventor, BioMedical Startup Co-Founder (Entrepreneur), and an Individual with Leadership educated within Universities, Hospitals/Clinical & Industries environment developing Drug Delivery Technology Platforms-Formulations-PK/PD Pre-Clinical Studies and seeking to make a major contribution toward overcoming barriers to therapeutics products development with the main Vision and Mission to treat human diseases for improving and transforming patients quality of life and hopes into reality.Qualifications & Skills:• BioMedical Startup Co-Founder (Entrepreneur).• Innovator/Inventor.• Experience in Building and Managing Strong Multidisciplinary and Cross-Functional Teams with background-expertise across disparate scientific, technological and medical fields.• Experience in working with manufacture industries (CDO/CDMO/CTO/CMO/CMC/CRO) on the help for manufacture prototype therapeutics products.• Experience in writing CMC Sections in INDs, BLA’s/MAA’s and response to inquiries and questions from Regulatory Agencies. • Strong background-expertise across disparate scientific, technological and medical fields.• Deep understanding and experience in complementary “in vitro” vs “ex vivo” vs “in vivo” Drugs/Genes Carrier & Delivery Technology Platforms.• Development Formulations and Technology Platforms for IV, IM, SC, INH, and ORAL administrations including Tablets, Capsules, Suspensions and Lyophilized Powders.• Hand-on experience (+15 years) in design, synthesis, research & development of drugs/genes delivery technologies-formulations, carrier and delivery platforms, oligonucleotides, nucleoside base modifications, proteins, peptides, small molecules synthesis & conjugation, potency/efficacy screening, drug and delivery carriers stability-degradation-metabolic studies, bioavailability-biodistribution-toxicity effects and PK-PD & Bioequivalence studies.• Extensive hand-on experience (+12 years) in design, synthesis, research & development and screening teaching-learning by structure-biological activity response evaluation of Nanoparticles as Carrier and Delivery Therapeutics Drugs/Genes Platforms by Quality by Design (QbD) & Design of Experiments (DOE) including LNPs, liposomes, polymers and co-polymers, hydrogels, peptides, micelles & proteins-based carries for “in vitro”, “ex vivo” & “in vivo” therapeutics studies.

Oscar R. Miranda, Phd/Mba/Be (He/Him)'s Current Company Details
CodeBridgeBio Inc.

Codebridgebio Inc.

Biopharmaceutical Drug Product Development; DDS/Formulation; PK/PD Studies; Innovator/Inventor; Preclinical Genes & Cells Therapeutics Product Development Scientific Director; Entrepreneur; and BioMedical Engineer Leader
Oscar R. Miranda, Phd/Mba/Be (He/Him) Work Experience Details
  • Codebridgebio Inc.
    Director Of Preclinical Genes And Cells Therapeutics Drug Product Development
    Codebridgebio Inc. Jul 2022 - Present
    Woburn, Massachusetts, United States
    Preclinical Genes and Cells Therapeutics Drug Product Development, DP Technological Platforms based on:1. RNAi (Gene Silencing)2. mRNA (Protein Expression)3. CRISPR-Cas (Gene Editing: KO & KI)4. CAR-T Engineering5. Immune Cell Engineering6. Hematopoietic Stem Cell Engineering7. Peptides or Cytokines8. Small Molecules 9. Gene & Cell Therapy 10. Vaccines
  • Novavax Inc
    Formulation And Process Development Senior Scientist/Team Lead, Protein Vaccine Team Member
    Novavax Inc Dec 2020 - Jul 2022
    Washington D.C. Metro Area
    In Novavax Inc (Nasdaq: NVAX), We use our proprietary recombinant protein technology platform, which combines genetic engineering’s power and speed to effectively produce highly immunogenic protein nanoparticles vaccine designed to address urgen health needs. We have more that a decade of experience contending with some of the world’s most devastating diseases including COVID-19, seasonal influenza, RSV, Ebola, MERS and SARS. Our final focused aim is make a substantial contribution to public health worldwide for improving everyone quality of life in this “new normal” era of changes and transformations post-pandemic.See Novavax link for more information:https://www.novavax.comHonors, Accomplishments, & Awards:1. “Novavax Supernova Rockstar Employee Award” Recipient: A Novavax (USA) appreciation award for the above and beyond levels of efforts demonstrated on the COVID-19 Vaccine Development (Nuvaxovid, CovoVax, NVX-CoV2373). Novavax COVID-19 Vaccine is the First Nanomedicine Protein-based Vaccine EUA in USA by the FDA and CDC endorsement.2. “Amex Card Recognition Award” Recipient: A Novavax (USA) appreciation award for leading the efforts to organize materials and shipping between MS&T, MM, Discovery, Formulation & Process Development Departments, and NVAX AB (Sweden) to complete European Medicines Agency EMA36 commitment under extremely tight deadlines during pandemic times.
    View
  • 1Globe Health Institute
    Biopharmaceutical Product Development Dds/Formulation Pk/Pd Studies Innovator & Sr Scientist Leader
    1Globe Health Institute Aug 2017 - Dec 2020
    Norwood, Massachusetts
    • Leading development of siRNA-LNPs/aiRNA-LNPs and others delivery carriers as well as development of delivery carries-formulations with poor water-soluble anticancer and nonanticancer drugs to target Liver and Tumor Models for iv and ORAL including Tablets, Capsules, Suspensions and Lyophilized Powders.• Strong knowledge and hand-on experience in biomaterials synthesis including small molecules, amphiphilic compounds, peptides, polysaccharides, polymers and lipids for biopharmaceutical drug delivery carriers.• Strong knowledge and hand-on experience in RNA synthesis and QC including MerMade 192/192X software and equipment, RNAs modification/functionalization, post-processing, annealing and characterization for RNAs ”in vitro” screening and potency testing.• Designing, synthetizing and developing lipids and phospholipid molecules for functional “in vivo” delivery carriers by Pharmaceutical “Quality by Design” (QbD) & DOE development approach to be incorporated into LNPs formulation. This development of functional carriers includes varying ionizable and non-ionizable lipids as well as its structures and compositions.• Rationalizing, visualizing and understanding the correlation structure-biological activity response of carriers ”in vivo” and its delivery criteria for engineering functional biomaterials that effectively complement and maximize “in vitro” delivery with “in vivo” delivery challenges including carriers reaching and maximizing target organs or tissues and carriers mechanism of action for delivery RNA or any Drug to the cell cytoplasm.• Applying bio-analytical, bio-physical and problem-solving skills in pre-clinical studies including qPCR, WB, ELISA, BCA/Isoindol derivatives protein assay, HPLC, MS/HRMS, Nanodrops, RiboGreen RNA quant., RNAs ”in vitro” screening and potency testing, Zetasizer, TEM, SEM, NMR, SAXS, ITC, Flow Cytometry and Confocal Microscopy.• Coordinating PK/PD “in vivo” studies with the preclinical development & pharmacology team.
    View
  • 1Globe Health Institute
    Targeted Therapeutics, Formulations And Genes/Sirna Delivery Senior Scientist And Head Leader
    1Globe Health Institute Jul 2015 - Jul 2017
    Norwood, Ma
    1Globe Health Institute | Cancer Therapeutics Research (GHI) is committed to the discovery, development and commercialization of targeted therapeutic agents for the treatment of several types of cancer and other disorders.GHI specializes in Asymmetrical Gene-Silencing RNA Technology (aiRNA, siRNA and siRNA Analogous, RNAi), Novel Nanotechnology DDS, and Synthetic Biology.At GHI, we are passionate about using innovative ideas and cutting-edge technology to combat hard-to-treat diseases. We are a growing company, created and operated by scientists who perform focused research to develop novel therapeutics along an accelerated timeline. Our team consists of a diverse and driven group of biological scientists and clinicians experienced in research and discovery, product development, finance, and clinical affairs.
    View
  • Massachusetts Institute Of Technology
    Post-Doctoral Associate, Biomedical Devices And Translational Research
    Massachusetts Institute Of Technology Mar 2014 - Jun 2015
    77 Massachusetts Avenue, Cambridge, Ma 02139
    The Elman Research Group focuses on the investigation and development of the next generation of biomedical devices based on the synergy of MOEMS (Micro-Opto-Electro-Mechanical-Systems), bionanotechnology and novel biomaterials, with the specific purpose of enhancing current diagnostic and therapeutic methods for chronic illnesses and acute conditions. Elman research group is clinically driven and operates as a technology incubator that addresses specific clinical needs for both civilian and military settings. The use of micro- and nano-systems is leveraged to create scalable devices that can be seamlessly integrated within the existing medical protocols.http://isnweb.mit.edu/students-and-post-docs.htmlhttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • Harvard Medical School
    Post-Doctoral Research Fellow, Biomedical Engineering
    Harvard Medical School Nov 2010 - Feb 2014
    Developing the Next Generation of Drug Delivery Systems, Stem Cells Based Systems and Biomaterials for Therapeutics Applications in Biomedicinehttp://www.karplab.net/team/alumnihttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • Brigham And Women'S Hospital
    Post-Doctoral Research Fellow, Biomedical Engineering
    Brigham And Women'S Hospital Nov 2010 - Feb 2014
    Developing the Next Generation of Drug Delivery Systems, Stem Cells Based Systems and Biomaterials for Therapeutics Applications in Biomedicinehttp://www.karplab.net/team/alumnihttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • Harvard-Mit Health Sciences And Technology (Hst)
    Post-Doctoral Research Fellow, Biomedical Engineering
    Harvard-Mit Health Sciences And Technology (Hst) Nov 2010 - Feb 2014
    Developing the Next Generation of Drug Delivery Systems, Stem Cells Based Systems and Biomaterials for Therapeutics Applications in Biomedicinehttp://www.karplab.net/team/alumnihttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • University Of Massachusetts Amherst
    Phd In Chemistry/Nanotechnology (Organic/Nanomaterials/Biology)
    University Of Massachusetts Amherst Sep 2005 - Feb 2011
    Worked on "Engineering Nanoparticles Surface for Biosensing and Biological Applications"Dissertation: Engineering Nanoparticles Surface for Biosensing: “Chemical Noses” to Detect and Identify Proteins, Bacteria and Cancerous CellsDissertation Date: Sep-2010Graduation Date: Feb-2011http://scholarworks.umass.edu/cgi/viewcontent.cgi?article=1340&context=open_access_dissertationshttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • Georgia Institute Of Technology
    Visiting Scientist, Biosensors
    Georgia Institute Of Technology Jan 2008 - Mar 2008
    Array-Based/Chemical Noses Biosensorshttp://scholarworks.umass.edu/cgi/viewcontent.cgi?article=1340&context=open_access_dissertationshttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • Villanova University
    Msc In Chemistry/Nanotechnology
    Villanova University Sep 2002 - Aug 2005
    Villanova 2003-2006 Publications:https://www1.villanova.edu/content/dam/villanova/artsci/chemistry/publications/Chem-publications2000-2010.pdfhttps://academictree.org/chemistry/tree.php?pid=95911
    View
  • Unido
    National Consultant In Industrial Development
    Unido Feb 1997 - Aug 2002
    Promoting and Development of Clusters and Productive Networks to Support Micro, Small and Medium Enterprises in Nicaragua: Project UNIDO US/NIC/02/05, Project UNIDO US/NIC/97/209 and Project UNIDO US/NIC/94/012http://pdf.usaid.gov/pdf_docs/Pnacr326.pdf (Page 16)
    View
  • Universidad Centroamericana, Managua
    Mba In Marketing
    Universidad Centroamericana, Managua Mar 1998 - Dec 2000
    Determining Competitive and Comparative Advantages of Dairy Products Clusters in Nicaragua: A Point of View to the Globalizationhttp://pdf.usaid.gov/pdf_docs/Pnacr326.pdf (Page 16)
    View
  • Universidad Nacional De Ingeniería
    Be In Chemical Engineering
    Universidad Nacional De Ingeniería Mar 1993 - Dec 1997
    Teaching Assistant in Mass and Heat Transfer
    View
  • Universidad Nacional De Ingeniería
    Laboratory Instructor In Chemical Engineering
    Universidad Nacional De Ingeniería Mar 1994 - Nov 1995
    Laboratory Instructor in Chemical Engineering: Organic, Thermodynamics, Mass and Heat Transfer
    View
  • Austrian Project Biomass
    Researcher In Chemical Engineering (Austrian Technical Cooperation Sucher & Holzer)
    Austrian Project Biomass Aug 1995 - Feb 1997
    Extraction of Polyelectrolyte of Moringa Oleifera Seeds their Purification in Ultra-filtration of Cross-flux and Optimization Processes using Jar Test
  • Ministry Of Economy And Development (Actually It Is Called Mific)
    Intellectual Technical Specialist In Patent Of Inventions, Intellectual Property (Ip)
    Ministry Of Economy And Development (Actually It Is Called Mific) Jan 1993 - Jun 1995
    Patents of Inventions (Chemistry)

Oscar R. Miranda, Phd/Mba/Be (He/Him) Skills

Coulter Counter Cancer Research Technology Synthesis Rheumatoid Arthritis Zetasizer Nano Zs Surface Modification Surface Chemistry Elisa Gel Electrophoresis Chemistry Hplc Dls Organic Synthesis Animal Models Biomaterials Biomedical Engineering Confocal Microscopy Circular Dichroism Nanoparticles Hiac Cell Culture Tga Tem Nanomedicine Biomedical Devices Cell Surface Modification Cell Sensing Toxicity Agarose Gel Electrophoresis Fluorescence Spectroscopy Parallel Flow Chamber Fluorescence Ftir Translational Research Molecular Biology Coulter Drug Delivery Cell Surface Cell Proliferation Aptamers Protein Sensing Rolling Circle Nanosight Synthesis And Engineering Surface Of Nanomaterials Sem Agarose Gel Diabetes Cell Proliferation. Viability Inflammatory Systems Research Biochemistry Biosensors Bacteria Sensing Mfi Uv/vis Regenerative Medicine Flow Cytometry Fluorescence Microscopy Peptide Synthesis Rolling Circle Amplification Nanotechnology Stem Cells

Oscar R. Miranda, Phd/Mba/Be (He/Him) Education Details

Frequently Asked Questions about Oscar R. Miranda, Phd/Mba/Be (He/Him)

What company does Oscar R. Miranda, Phd/Mba/Be (He/Him) work for?

Oscar R. Miranda, Phd/Mba/Be (He/Him) works for Codebridgebio Inc.

What is Oscar R. Miranda, Phd/Mba/Be (He/Him)'s role at the current company?

Oscar R. Miranda, Phd/Mba/Be (He/Him)'s current role is Biopharmaceutical Drug Product Development; DDS/Formulation; PK/PD Studies; Innovator/Inventor; Preclinical Genes & Cells Therapeutics Product Development Scientific Director; Entrepreneur; and BioMedical Engineer Leader.

What is Oscar R. Miranda, Phd/Mba/Be (He/Him)'s email address?

Oscar R. Miranda, Phd/Mba/Be (He/Him)'s email address is om****@****vax.com

What is Oscar R. Miranda, Phd/Mba/Be (He/Him)'s direct phone number?

Oscar R. Miranda, Phd/Mba/Be (He/Him)'s direct phone number is +148446*****

What schools did Oscar R. Miranda, Phd/Mba/Be (He/Him) attend?

Oscar R. Miranda, Phd/Mba/Be (He/Him) attended Massachusetts Institute Of Technology, Harvard Medical School, Harvard Clinical And Translational Science Center, Harvard University, Harvard Clinical And Translational Science Center, University Of Massachusetts Amherst, Georgia Institute Of Technology, Villanova University, Universidad Centroamericana, Managua, Universidad Nacional De Ingeniería.

What are some of Oscar R. Miranda, Phd/Mba/Be (He/Him)'s interests?

Oscar R. Miranda, Phd/Mba/Be (He/Him) has interest in Biosensor, Translational Medicine, Peptides And Peptoids, Animal Models, Biomedical Engineering, Surface Engineering, Dna, See 14, Diagnostic, Bio Micro And Nano Materials.

What skills is Oscar R. Miranda, Phd/Mba/Be (He/Him) known for?

Oscar R. Miranda, Phd/Mba/Be (He/Him) has skills like Coulter Counter, Cancer Research, Technology, Synthesis, Rheumatoid Arthritis, Zetasizer Nano Zs, Surface Modification, Surface Chemistry, Elisa, Gel Electrophoresis, Chemistry, Hplc.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.